Evan Wang
Stock Analyst at Guggenheim
(0)
# 5208
Out of 5,243 analysts
7
Total ratings
0.00%
Success rate
-74.75%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Spruce Biosciences | Reiterates: Neutral | n/a | n/a | n/a | 3 | Dec 12, 2024 | |
CureVac | Reiterates: Neutral | n/a | n/a | n/a | 1 | Apr 5, 2024 | |
Invivyd | Upgrades: Buy | 9 | 0.41 | 2095.12% | 1 | Apr 5, 2024 | |
Valneva | Maintains: Buy | 18 17 | 4.31 | 294.43% | 1 | Mar 22, 2024 | |
Moderna | Initiates Coverage On: Neutral | n/a | n/a | n/a | 1 | Apr 26, 2023 |